Page last updated: 2024-09-03

ruboxyl and Waldenstrom Macroglobulinemia

ruboxyl has been researched along with Waldenstrom Macroglobulinemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doria, G; Franchi, F; Konovalova, N; Pioli, C; Rossetti, R; Rossi Fanelli, F; Seminara, P; Tubani, L	1

Trials

1 trial(s) available for ruboxyl and Waldenstrom Macroglobulinemia

Article	Year
Activity of a nitroxylated analog of daunorubicin, ruboxyl, in B-lymphoproliferative disorders. Acta haematologica, 2001, Volume: 105, Issue:2 Topics: Aged; Aged, 80 and over; Animals; Antibiotics, Antineoplastic; B-Lymphocytes; Cells, Cultured; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Myeloma; Pilot Projects; Remission Induction; Spleen; T-Lymphocytes; Waldenstrom Macroglobulinemia	2001

Article

Year

Activity of a nitroxylated analog of daunorubicin, ruboxyl, in B-lymphoproliferative disorders.

Acta haematologica, 2001, Volume: 105, Issue:2

Topics: Aged; Aged, 80 and over; Animals; Antibiotics, Antineoplastic; B-Lymphocytes; Cells, Cultured; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Myeloma; Pilot Projects; Remission Induction; Spleen; T-Lymphocytes; Waldenstrom Macroglobulinemia

2001